KRMD (KORU Medical Systems) LT-Debt-to-Total-Asset: 0.10 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KRMD KORU Medical Systems Inc KRMD
77 GF Score
Price $4.23
GF Value $4.09
Valuation Fairly Valued
View Full Analysis

What is KORU Medical Systems LT-Debt-to-Total-Asset?

KORU Medical Systems KRMD -1.17% 77 LT-Debt-to-Total-Asset is 0.10 as of Mar. 2026. GuruFocus rates KRMD with a GF Score™ of 77/100 and a GF Value™ of $4.09 (Fairly Valued).

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. KORU Medical Systems's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.10.

KORU Medical Systems's long-term debt to total assets ratio declined from Mar. 2025 (0.11) to Mar. 2026 (0.10). It may suggest that KORU Medical Systems is progressively becoming less dependent on debt to grow their business.

KORU Medical Systems  (NAS:KRMD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

KORU Medical Systems LT-Debt-to-Total-Asset Related Terms

KORU Medical Systems LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for KORU Medical Systems's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems LT-Debt-to-Total-Asset Chart

KORU Medical Systems Annual Data
Trend Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.10 0.13 0.12 0.11

KORU Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.12 0.10 0.11 0.10
KRMD
77GF Score
KORU Medical Systems Inc KRMD
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KORU Medical Systems LT-Debt-to-Total-Asset Calculation

KORU Medical Systems's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=2.958/28.2
=0.10

KORU Medical Systems's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=2.818/28.592
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.10 mean?
KORU Medical Systems (KRMD) has a LT-Debt-to-Total-Asset of 0.10 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on KORU Medical Systems and its competitors.
Is KORU Medical Systems' LT-Debt-to-Total-Asset too high?
KORU Medical Systems' current LT-Debt-to-Total-Asset is 0.10. Overall, KORU Medical Systems has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' LT-Debt-to-Total-Asset compare to EMBC and PDEX?
KORU Medical Systems' LT-Debt-to-Total-Asset of 0.10 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on KORU Medical Systems and its competitors. KORU Medical Systems's current LT-Debt-to-Total-Asset is 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.09, compared to a current price of $4.23 — trading 3.4% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.10. KORU Medical Systems' overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current LT-Debt-to-Total-Asset is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued. The current stock price of $4.23 is trading 3.4% above its estimated GF Value™ of $4.09. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

  • LT-Debt-to-Total-Asset: 0.10
  • GF Value™: $4.09 vs. price of $4.23 (3.4% above fair value)
  • GF Score™: 77/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
77GF Score

Get the complete analysis for KRMD

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.23
Price
$4.09
GF Value